The short answer
Have your prescriber review red yeast rice before combining it with simvastatin. Products containing appreciable monacolin K add statin-like exposure and could overlap in harmful effects. The inspected combination studies do not establish whether adding these products increases liver-injury risk with simvastatin; their short follow-up also cannot rule out harm.
What this answer covers
Oral red yeast rice supplements with simvastatin. Monacolin content and additional ingredients determine how closely a studied product matches a bottle.
- Supplement or preparation
- red yeast rice
- Medication ingredient
- simvastatin
Why can a supplement overlap with a statin?
Red yeast rice can contain monacolin K, which is chemically identical to lovastatin. Products vary greatly in this content, and some contain very little. Consequently, the supplement name alone does not tell you how much additional statin-like exposure it provides.
What does the combination research show?
A 2026 trial enrolled 1,110 participants across four groups, including simvastatin with a specified natto-red-yeast-rice preparation. Over three months, adverse-event rates were similar across groups. The similar event rates are reassuring within this three-month study, but do not establish long-term safety for other preparations.
Is liver injury therefore proven or ruled out?
Monacolin K can cause statin-like liver and muscle effects. Whether adding a particular red yeast rice product increases liver-injury risk during simvastatin treatment remains uncertain. The short combination studies cannot resolve uncommon or delayed harm. A prescriber can assess possible duplicate therapy and your other risk factors.
Would taking it at another time solve the problem?
A few hours of separation has not been shown to prevent overlapping statin-like effects. Bring the product label and reason for adding it to your clinician. Seek advice for muscle symptoms or signs of liver trouble, and do not replace prescribed cholesterol treatment with the supplement yourself.
Evidence and practical considerations
Side effects & toxicity
Have your prescriber review red yeast rice before combining it with simvastatin. Products containing appreciable monacolin K add statin-like exposure and could overlap in harmful effects. The inspected combination studies do not establish whether adding these products increases liver-injury risk with simvastatin; their short follow-up also cannot rule out harm.
- Exact scope
- Oral red yeast rice supplements with simvastatin. Monacolin content and additional ingredients determine how closely a studied product matches a bottle. with Exact RxNorm 36567, IN, simvastatin; ZOCOR oral tablets. No substitution of lovastatin, pravastatin or another statin.
- Medication form and route
- oral
What remains uncertain
- The studies do not establish the incremental liver-injury risk of adding the specified red yeast rice product to simvastatin. Product composition, short follow-up and limited safety comparisons prevent both confirming that risk and excluding harm. General monacolin toxicity supports caution but is not direct proof of an added exact-pair effect.
Factors that may matter: Exact preparation, dose, other medicines and baseline clinical condition matter..
Read the supporting source summaries
Source 1: government clinical information
nccih.nih.gov · Source check Sep 10, 2026
Population: People using red yeast rice products.
Products with substantial monacolin K can produce statin-like muscle, liver and kidney effects.
How this applies: Restricted to the exact identities and conditions described in this article.
General product hazard does not establish an increased exact-pair liver-injury rate; no guaranteed safe monacolin level is supplied.
Source 2: regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral simvastatin.
Advises avoiding grapefruit juice and describes dose- and population-qualified niacin muscle precautions.
How this applies: Restricted to the exact identities and conditions described in this article.
Does not establish a numerical risk for every juice, nutritional niacin dose or red yeast rice preparation.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 1,110 adults assigned to four groups.
Adverse-event rates were similar. Added LDL benefit over simvastatin was significant at one month but not at three months.
How this applies: Restricted to the exact identities and conditions described in this article.
Specific mixed preparation, selected doses and short follow-up; not generic red yeast rice or proof of long-term liver safety.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Original-source assessment and consumer article prepared; exact claim dispositions, neutral findings and preparation limits recorded. | |
| Clinical sign-off is pending and no publication approval is asserted. | |
| Clarified evidence limits and source details after an independent editorial audit. Clinical review is still pending. | |
| Research summary published |
Article revision: 17842d5a4cc81ccb
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.